← Leaderboards
Scott Tenenbaum
Sxrna Technologies, Inc.
$557,257
Attributed
$807,257
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $500K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$807,257 · 2
By mechanism
R41$807,257 · 2
Top collaborators
- Janet L Paluh1 shared
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposMicrornasComplexStructureTranslationsCell Culture TechniquesGenesExcisionPlaySmall Business Technology Transfer ResearchUntranslated RnaBindingTechnologyProteinsCellsCommercializationDesignEngineeringMessenger RnaBinding SitesBinding ProteinsCell LineAreaAlginates
Grant awards (2)
sxRNA-Select: Using RNAs for Positive Selection of Cell Lines, Enabling High-Yield Biotherapeutic Production$307,257
R41 · FY2025 · GM · contact PI
Creating an sxRNA Organoid Product for Advancing the Study, Prevention and Treatment of Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD)$500,000
R41 · FY2023 · AG · contact PI